Form 8-K Horizon Pharma plc For: Apr 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Horizon Pharma (HZNP) Affirms FY 2016 Net Sales Guidance
April 12, 2016 8:09 AM EDTHorizon Pharma (NASDAQ: HZNP) disclosed in an SEC filing:
On April 12, 2016, Horizon Pharma plc made publicly available an updated investor presentation that contains projections of net sales and adjusted EBITDA for the first quarter ended March 31, 2016, the second quarter 2016, as well as prescription results for certain of Horizon Pharmas medicines during the first quarter of 2016. The presentation is furnished as Exhibit 99.1 hereto, and will also be available on the investor relations section of Horizon Pharmas web... More
Horizon Pharma (HZNP) Offers H116 Net Sales, adj.-EBITDA Outlook; Provides Q1 Prescription Results
April 12, 2016 8:07 AM EDTHorizon Pharma (NASDAQ: HZNP) disclosed the following on Tuesday:
Item 2.02Results of Operations and Financial ConditionOn April 12, 2016, Horizon Pharma plc made publicly available an updated investor presentation that contains projections of net sales and adjusted EBITDA for... More
